IRLAB Therapeutics AB Market Cap

IRLAB Therapeutics AB has a market cap or net worth of 126.39 million as of April 28, 2026. Its market cap has decreased by -65.63% in one year.

Market Cap

126.39M

Enterprise Value

74.48M

Revenue

57.46M

Ranking

n/a

PE Ratio

n/a

Stock Price

1.49

Market Cap Chart

Since February 28, 2017, IRLAB Therapeutics AB's market cap has decreased from 413.00M to 126.39M, a decrease of -69.40%. That is a compound annual growth rate of -12.12%.

Market Cap History

Date	Market Cap	% Change
Apr 28, 2026	126.39M	-24.47%
Dec 30, 2025	167.33M	-69.99%
Dec 30, 2024	557.59M	43.33%
Dec 29, 2023	389.01M	-80.42%
Dec 30, 2022	1.99B	-12.75%
Dec 30, 2021	2.28B	4.76%
Dec 30, 2020	Pro	Pro
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
NextCell Pharma AB	130.33M
Annexin Pharmaceuticals AB	112.24M
Simris Group AB (PUBL)	107.44M
Alligator Bioscience AB	151.06M
Scandinavian ChemoTech AB	99.02M
Magle Chemoswed Holding AB	97.05M
Elicera Therapeutics AB	156.04M
AlzeCure Pharma AB	160.88M

Market Cap Rankings